Warning: The NCBI web site requires JavaScript to function. more...
Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming.
Gonçalves ED, Bonato VL, da Fonseca DM, Soares EG, Brandão IT, Soares AP, Silva CL.
Genet Vaccines Ther. 2007 Aug 22;5:7.
Related citations
[Recent progress in mycobacteriology].
Okada M, Kobayashi K.
Kekkaku. 2007 Oct;82(10):783-99. Japanese.
Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes.
Rosada RS, de la Torre LG, Frantz FG, Trombone AP, Zárate-Bladés CR, Fonseca DM, Souza PR, Brandão IT, Masson AP, Soares EG, Ramos SG, Faccioli LH, Silva CL, Santana MH, Coelho-Castelo AA.
BMC Immunol. 2008 Jul 22;9:38.
[Novel vaccines against M. tuberculosis].
Okada M.
Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.
Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
Tuberculosis (Edinb). 2009 Jan;89(1):54-61. Epub 2008 Dec 3.
A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA, Ramsay AJ, Buchan GS, Keen DL, Ranasinghe C, Slobbe L, Collins DM, de Lisle GW, Buddle BM.
Immunology. 2003 Apr;108(4):548-55.
A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge.
Gao H, Yue Y, Hu L, Xu W, Xiong S.
Vaccine. 2009 Aug 27;27(39):5313-9. Epub 2009 Jul 16.
A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.
Skinner MA, Buddle BM, Wedlock DN, Keen D, de Lisle GW, Tascon RE, Ferraz JC, Lowrie DB, Cockle PJ, Vordermeier HM, Hewinson RG.
Infect Immun. 2003 Sep;71(9):4901-7.
[Frontier of mycobacterium research--host vs. mycobacterium].
Okada M, Shirakawa T.
Kekkaku. 2005 Sep;80(9):613-29. Japanese.
A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge.
Cai H, Yu DH, Hu XD, Li SX, Zhu YX.
DNA Cell Biol. 2006 Aug;25(8):438-47.
Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
Santosuosso M, McCormick S, Zhang X, Zganiacz A, Xing Z.
Infect Immun. 2006 Aug;74(8):4634-43.
DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
Yoshida S, Tanaka T, Kita Y, Kuwayama S, Kanamaru N, Muraki Y, Hashimoto S, Inoue Y, Sakatani M, Kobayashi E, Kaneda Y, Okada M.
Vaccine. 2006 Feb 20;24(8):1191-204. Epub 2005 Sep 19.
Neonatal vaccination with Mycobacterium bovis BCG: potential effects as a priming agent shown in a heterologous prime-boost immunization protocol.
Rahman MJ, Fernández C.
Vaccine. 2009 Jun 19;27(30):4038-46. Epub 2009 May 3.
Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice.
Haile M, Hamasur B, Jaxmar T, Gavier-Widen D, Chambers MA, Sanchez B, Schröder U, Källenius G, Svenson SB, Pawlowski A.
Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):107-14. Epub 2005 Jan 20.
Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
Dou J, Tang Q, Yu F, Yang H, Zhao F, Xu W, Wang J, Hu W, Hu K, Liou C, Feng He X, Wang Y.
Immunobiology. 2010;215(2):133-42. Epub 2009 May 17.
Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM, Bai YL, Shi CH, Gao H, Xue Y, Jiang H, Xu ZK.
APMIS. 2008 Dec;116(12):1071-81.
Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting.
Vordermeier HM, Lowrie DB, Hewinson RG.
Vet Microbiol. 2003 Jun 10;93(4):349-59.
Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
Dou J, Wang Y, Yu F, Yang H, Wang J, He X, Xu W, Chen J, Hu K.
Int J Immunogenet. 2011 Dec 8. doi: 10.1111/j.1744-313X.2011.01066.x. [Epub ahead of print]
Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
McShane H, Brookes R, Gilbert SC, Hill AV.
Infect Immun. 2001 Feb;69(2):681-6.
Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
Luo Y, Wang B, Hu L, Yu H, Da Z, Jiang W, Song N, Qie Y, Wang H, Tang Z, Xian Q, Zhang Y, Zhu B.
Vaccine. 2009 Oct 19;27(44):6179-85. Epub 2009 Aug 25.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on